Purpose Immune system modulation, with the use of immune checkpoint inhibitors, has
drastically changed the field of oncology. Strong preclinical data indicate that radiation …

Ionizing radiation can have a wide range of impacts on tumor–immune interactions, which
are being studied with the greatest interest and at an accelerating pace by the medical …

We performed a prospective study of circulating immune cell changes after stereotactic body
radiotherapy (SBRT) in 50 early-stage NSCLC patients. We found no significant increase in …

Objectives Although the effects of estimated dose of radiation to immune cells (EDRIC) in
stage III NSCLC, LA-NSCLC, LS-SCLC and esophageal cancer on clinical outcomes have …

Background Clinically, there is a lack of simple and feasible indicators to predict the efficacy
of stereotactic body radiation therapy (SBRT). Circulating lymphocyte counts (CLCs) is …

Simple Summary Despite major research and clinical efforts, lung cancer remains the
leading cause of cancer-related death. Stereotactic body radiotherapy (SBRT) has emerged …

Background Prior studies suggest lymphopenia, systemic immune-inflammatory index, and
tumor response all impact clinical outcomes in Stage III NSCLC. We hypothesized that tumor …

Stereotactic body radiation therapy (SBRT) is the standard treatment for patients who are
medically inoperable or who refuse surgery with stage I non-small cell lung cancer …

The immunologic effects of nonuniform dose irradiation - Book chapter - IOPscience This
site uses cookies. By continuing to use this site you agree to our use of cookies. To find out …

Aim: According to earlier research, tumour response, Lymphocytopenia, and a system-wide
immuneinflammatory indexes all affect the clinical results of Stage III NSCLC. We postulated …